Kyeongki-do, South Korea

Hong Woo Lee


Average Co-Inventor Count = 7.6

ph-index = 2

Forward Citations = 53(Granted Patents)


Location History:

  • Kyeongki-do, KR (1997)
  • Kwangmyeong, KR (1998)
  • Kyunggi, KR (2000)

Company Filing History:


Years Active: 1997-2000

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations of Hong Woo Lee

Introduction

Hong Woo Lee is a notable inventor based in Kyeongki-do, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that inhibit angiogenesis. With a total of three patents to his name, his work has implications for medical treatments and drug development.

Latest Patents

One of his latest patents involves 5-demethoxyfumagillol derivatives and processes for preparing the same. These compounds are useful as angiogenesis inhibiting agents, and the patent discloses a pharmaceutical composition that includes these compounds as an active ingredient. Another significant patent is for 2-(2-substituted pyrrolidin-4-yl) thio-carbapenem derivatives, which relates to a mercaptopyrrolidinyl derivative suitable for the preparation of carbapenem compounds.

Career Highlights

Hong Woo Lee is associated with Chong Kun Dang Corporation, where he continues to innovate and contribute to the pharmaceutical industry. His work is characterized by a focus on developing new compounds that can lead to effective medical treatments.

Collaborations

He has collaborated with notable coworkers such as Hyo Sung Kwak and Chong Ryul Lee, further enhancing the research and development efforts within his field.

Conclusion

Hong Woo Lee's contributions to pharmaceutical innovations demonstrate his commitment to advancing medical science through his inventive work. His patents reflect a dedication to creating effective solutions for health challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…